Inventor · disambiguated record
Eric J. Sorscher
Also filed as: SORSCHER ERIC · SORSCHER ERIC J
15 granted patents·9 pending applications·285 citations·filing 1993–2023
92Inventor score
Top patents by PatentIndex Score
24 records- 0193US10241028B2Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography proceduresROWE STEVEN M·Filed 2012·Granted Mar 26, 2019·22 cites·19 claims
- 0289US10942112B2Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography proceduresMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Mar 9, 2021·4 cites·21 claims
- 0385US5552311APurine nucleoside phosphorylase gene therapy for human malignancyUNIV ALABAMA RES FOUND·Filed 1993·Granted Sep 3, 1996·103 cites·14 claims
- 0483US6491905B1Recombinant bacterial cells for delivery of PNP to tumor cellsUAB RESEARCH FOUNDATION·Filed 1998·Granted Dec 10, 2002·60 cites·21 claims
- 0582US6958318B2Recombinant bacterial cells for delivery of PNP to tumor cellsSOUTHERN RES INST·Filed 2002·Granted Oct 25, 2005·14 cites·5 claims
- 0680US6017896APurine nucleoside phosphorylase gene therapy for human malignancyUNIV ALABAMA RES FOUND·Filed 1997·Granted Jan 25, 2000·60 cites·12 claims
- 0778US7037718B2Mutant purine nucleoside phosphorylase proteins and cellular delivery thereofUAB RESEARCH FOUNDATION·Filed 2001·Granted May 2, 2006·13 cites·9 claims
- 0875US12453760B2Enhanced therapeutic usage of a purine nucleoside phosphorylase or nuceloside hydrolase prodrugUAB RES FOUND·Filed 2021·Granted Oct 28, 2025·0 cites·9 claims
- 0970US8628767B2Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugsPARKER WILLIAM B·Filed 2009·Granted Jan 14, 2014·1 cites·7 claims
- 1068US10080784B2Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrugPARKER WILLIAM B·Filed 2012·Granted Sep 25, 2018·1 cites·15 claims
- 1168US7488598B2Mutant purine nucleoside phosphorylase proteins and cellular delivery thereofCORNELL CT FOR TECHNOLOGY ENTP·Filed 2002·Granted Feb 10, 2009·4 cites·33 claims
- 1264US12465595B2Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pharmaceutical compositions, and uses thereofUNIV EMORY·Filed 2021·Granted Nov 11, 2025·0 cites·7 claims
- 1361US2025361243A1Compounds and Pharmaceutical Compositions Useful for Managing Sickle Cell Disease and Conditions Related TheretoUNIV EMORY·Filed 2023·Application pending·0 cites
- 1461US2025114343A1Treatment of BronchiectasisUNIV EMORY·Filed 2023·Application pending·0 cites
- 1556US2018360929A1Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrugUAB RES FOUND·Filed 2018·Application pending·0 cites
- 1654US2014199285A1Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugsPARKER WILLIAM B·Filed 2014·Application pending·0 cites
- 1753US7473527B2Compounds promoting delivery of genesUAB RESEARCH FOUNDATION·Filed 2003·Granted Jan 6, 2009·0 cites·32 claims
- 1853US2016022784A1Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugsUNIV CORNELL·Filed 2015·Application pending·0 cites
- 1952US2002035138A1Activating Cl- secretionSOUTHERN RES INST·Filed 2001·Application pending·0 cites
- 2050US2023102924A1Methods of Treating Cancer Using Checkpoint Inhibitors in Combination with Purine Cleaving EnzymesUNIV EMORY·Filed 2021·Application pending·0 cites
- 2144US2004204375A1Gene delivery compoundsFiled 2002·Application pending·0 cites
- 2237US2010151572A1Anti-tumoral compositions methodsSORSCHER ERIC J·Filed 2006·Application pending·0 cites
- 2331US6605281B1Human papillomavirus vectors for the episomal transduction of host cells and method of making sameUAB RESEARCH FOUNDATION·Filed 1998·Granted Aug 12, 2003·3 cites·6 claims
- 2431US6251930B1Activating C1- secretionSOUTHERN RES INST·Filed 1998·Granted Jun 26, 2001·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Eric J. Sorscher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →